- Home
- CLDT vs PRLD Comparison
CLDT vs PRLD Comparison
Compare CLDT & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDT | PRLD |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.5M | 529.1M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CLDT | PRLD |
|---|---|---|
| Price | $13.08 | $5.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $11.00 | $5.67 |
| AVG Volume (30 Days) | 274.1K | ★ 508.3K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | ★ 275.00 | 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $295,075,000.00 | $12,140,000.00 |
| Revenue This Year | $2.94 | $320.10 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | $610.21 | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $6.08 | $0.98 |
| 52 Week High | $13.89 | $6.83 |
Technical Indicators
Market Signals| Indicator | CLDT | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 45.20 | 49.78 |
| Support Level | $12.19 | $3.75 |
| Resistance Level | $13.80 | $5.69 |
| Average True Range (ATR) | 0.34 | 0.50 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 24.80 | 20.83 |
Price Performance
Historical ComparisonAbout CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.